Point72 Asset Management, L.P. - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 143 filers reported holding INSYS THERAPEUTICS INC NEW in Q3 2016. The put-call ratio across all filers is 1.43 and the average weighting 0.0%.

Quarter-by-quarter ownership
Point72 Asset Management, L.P. ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2017$4,572,000
+42.6%
435,000
+24.8%
0.02%
+13.6%
Q4 2016$3,207,000
-25.9%
348,627
-5.0%
0.02%
-26.7%
Q3 2016$4,329,000
+128.4%
367,143
+1026.2%
0.03%
+130.8%
Q1 2015$1,895,000
-92.6%
32,600
-94.6%
0.01%
-92.7%
Q4 2014$25,454,000
-2.9%
603,750
-10.7%
0.18%
-9.1%
Q3 2014$26,206,000
+397.4%
675,765
+300.6%
0.20%
+479.4%
Q2 2014$5,269,000168,7000.03%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q3 2016
NameSharesValueWeighting ↓
Orbimed Advisors 5,406,844$52,014,0000.66%
ETF MANAGERS GROUP, LLC 282,268$3,255,0000.24%
Mirae Asset Global Investments Co., Ltd. 1,470,996$14,151,0000.19%
Financial Gravity Companies, Inc. 4,467$42,0000.05%
GSA CAPITAL PARTNERS LLP 67,200$646,0000.04%
TCI Wealth Advisors, Inc. 7,766$75,0000.03%
Freedom Investment Management, Inc. 64,741$623,0000.03%
GAM Holding AG 83,940$808,0000.02%
SFMG, LLC 11,994$115,0000.02%
SHELL ASSET MANAGEMENT CO 95,127$915,0000.02%
View complete list of INSYS THERAPEUTICS INC NEW shareholders